|
|
Volumn 50, Issue 11, 2011, Pages 1464-1465
|
|
Second line AUO (Working Group Urological Oncology) study AB 35/09 on metastasized urothelial carcinoma : Phase II study with RAD001 in combination with paclitaxel for patients with metastasized urothelial carcinoma of the urinary bladder after failure of platinum-based chemotherapy (CRAD001);Second-line-AUO-Studie AB 35/09 beim metastasierten Urothelkarzinom : Phase-II-Studie mit RAD001 in Kombination mit Paclitaxel für Patienten mit metastasiertem Urothelkarzinom der Harnblase nach Versagen einer vorherigen platinbasierten Chemotherapie (CRAD001)
a
a
MeckE Vidence
*
(Germany)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PACLITAXEL;
BLADDER METASTASIS;
CANCER CHEMOTHERAPY;
DRUG EFFICACY;
HUMAN;
PHASE 2 CLINICAL TRIAL (TOPIC);
SHORT SURVEY;
TRANSITIONAL CELL CARCINOMA;
TREATMENT FAILURE;
TREATMENT RESPONSE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
HUMANS;
PACLITAXEL;
SIROLIMUS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
|
|
EID: 80755130406
PISSN: 03402592
EISSN: 14330563
Source Type: Journal
DOI: 10.1007/s00120-011-2754-9 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
